3-Oxo-1,3-dihydroisobenzofuran-5-carbonitrile

Catalog No. :
ACSJVH518
CAS No. :
89877-62-3
Molecular Formula :
C9H5NO2
Molecular Weight :
159.14

IUPAC Name:3-oxo-1,3-dihydroisobenzofuran-5-carbonitrile

3-Oxo-1,3-dihydroisobenzofuran-5-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$111.00Login to see priceIn stockInquiry
5g97%$554.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Oxo-1,3-dihydroisobenzofuran-5-carbonitrile
IUPAC Name3-oxo-1,3-dihydroisobenzofuran-5-carbonitrile
MDL No.MFCD03428560
Molecular FormulaC9H5NO2
Molecular Weight159.14
SMILESO=C1OCC2=CC=C(C=C12)C#N
InChI KeySHFPTPKYWROKQJ-UHFFFAOYSA-N
Synonym1,3-Dihydro-1-oxoisobenzofuran-6-carbonitrile;3-oxo-1,3-dihydro-2-benzofuran-5-carbonitrile;3-Oxo-1,3-dihydroisobenzofuran-5-carbonitrile;Chlortalidone Impurity 18;Chlortalidone Impurity 8;3-oxo-1H-2-benzofuran-5-carbonitrile;5-Isobenzofurancarbonitrile, 1,3-dihydro-3-oxo-
CAS No.89877-62-3
PubChem CID13289562

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACSJVH518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCANX947 route compound structure diagram
    ACCANX94719477-73-7 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACSJVH518 route product structure diagram
    ACSJVH51889877-62-3 In Stock
Inquiry

2. ACSJVH518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  2. Plus
  3. ACCANX947 route compound structure diagram
    ACCANX94719477-73-7 In Stock
  4. Then
  5. ACSJVH518 route product structure diagram
    ACSJVH51889877-62-3 In Stock
Inquiry

Comments (0)